Patents by Inventor Hubert Kuhn

Hubert Kuhn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8834787
    Abstract: The present invention relates to complexed metal salts which comprise ligands and at least one complexing agent for chemically binding noxious substances and/or odor-forming substances, the ligands comprising a hydrophobic carbon skeleton with hydrophilic groups. The complexed metal salt formed with the complexing agent is water-soluble and surface-active. Preferred complexing agents are water-soluble acids or salts of at least bifunctional acids, or also ether carboxylic acids.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: September 16, 2014
    Assignee: CAM-D Technologies GmbH
    Inventors: Hubert Kuhn, Gordon Thie
  • Publication number: 20110123393
    Abstract: The present invention relates to complexed metal salts which comprise ligands and at least one complexing agent for chemically binding noxious substances and/or odour-forming substances, the ligands comprising a hydrophobic carbon skeleton with hydrophilic groups. The complexed metal salt formed with the complexing agent is water-soluble and surface-active. Preferred complexing agents are water-soluble acids or salts of at least bifunctional acids, or also ether carboxylic acids.
    Type: Application
    Filed: November 14, 2008
    Publication date: May 26, 2011
    Inventors: Hubert Kuhn, Gordon Thie
  • Publication number: 20060222621
    Abstract: Solid odor absorbers including a solid carrier with a nanostructured surface and, incorporated therein, active zinc ricinoleate as an odor absorber are provided.
    Type: Application
    Filed: March 8, 2006
    Publication date: October 5, 2006
    Inventors: Hubert Kuhn, Felix Muller, Jorg Peggau, Gordon Thie
  • Publication number: 20050287225
    Abstract: The invention relates to metal cluster nano-compounds of transition metals, which includes a metal nucleus formed from atoms of at least one transition metal and at least one ligand, and including their physiologically compatible salts, derivatives, isomers, hydrates, metabolites and prodrugs, which are suited for the prophylactic and/or therapeutic (curative) treatment of diseases of the human or animal body, particularly of tumor or cancer diseases. To this end, the inventive compounds can, under physiological conditions, interact with the DNA, preferably B-DNA, of the relevant cells.
    Type: Application
    Filed: July 31, 2003
    Publication date: December 29, 2005
    Inventors: Gunter Schmid, Hubert Kuhn, Maria Tsoli